Patients as Partners Europe Agenda 2025 Page 2

Patient Keynote: If I Only Knew This?

Showing Events in 1 Track from 09:00am to 10:20am

Patient Keynote, Perspectives and Measuring Value Galleon Suites B & C

9:00AM - 9:25AM

Creating the Right Environment for Patients to Provide Effective Insights into Clinical Trial Development

9:25AM - 9:55AM

Sarah Davies, Senior Director, Patient Strategy, Lumanity

Andy Collinson, Patient, Advocate

Daniel Newman, Patient, Advocate

Amanda Simonds, Global Patient Engagement & Advocacy Lead, Dermatology, UCB

9:55AM - 10:20AM

Measuring and Demonstrating the Value of Patient Engagement Across the Medicine Lifecycle

Christina Hughes, BS, MBA, Chief Operating Officer, Reverba Global

Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi

Anders Blaedel Lassen, Senior Director, Patient Insights, Lundbeck

Pascal Piedbois, MD, PhD, CMO, One2Treat

Showing Events in 1 Track from 10:20am to 10:55am

Morning Networking with Tea/Coffee and Biscuits

10:20AM - 10:55AM

Morning Networking with Tea/Coffee and Biscuits

Showing Events in 1 Track from 11:00am to 12:50pm

Partnerships, Advocacy and Turning Insights into Action Galleon Suites B & C

11:00AM - 11:25AM

Johnson & Johnson Innovative Medicine on an End-to-End Matrix Approach to Patient Advocacy and Engagement

Wafae Iraqi, PharmD, PhD, EMEA Patient Engagement Therapeutic Area Lead, Johnson & Johnson Innovative Medicine

Beyza Klein, Director, Patient Advocacy R&D, Johnson & Johnson Innovative Medicine

11:25AM - 11:50AM

Patient Partnerships in Action: Integrating Patient Expertise into Product Innovation and Development

Lorna Allen, Involvement Manager, Cystic Fibrosis Trust

Rebecca Holmes, PhD, Scientific Director, LifeArc

Connie Takawira, Partnerships Manager, Medicines Discovery Catapult

11:50AM - 12:05PM

Patient Experience Journey Mapping – Methodology, Dissemination and Strategic Impact

Oleksandr Gorbenko, MD, PhD, BCMAS, Global Patient Affairs Director, Neurosciences, Ipsen

Ishmam Nawar, Communications Consultant, Oxford PharmaGenesis

12:05PM - 12:50PM

Interactive Session: Mapping the Patient Journey in Clinical Trials

Led By:

Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi

Kate Moss, Lead Partner, Pharmaceuticals & Life Sciences, Baringa

GSK on Advances in Decentralized Clinical Trials & Engaging with Patients Digitally

Showing Events in 1 Track from 12:50pm to 01:45pm

Lunch

12:50PM - 1:45PM

Lunch

Showing Events in 1 Track from 01:50pm to 03:20pm

DCT, Behavioural Science and Global Recruitment Galleon Suites B & C

1:50PM - 2:10PM

Laura Renton, Digital Enablement Lead, GSK

2:10PM - 2:35PM

Who are Trusted Messengers for Patient Engagement in Real World Data Studies? A Behavioural Science Approach

Speaker:

Sally Dews, Director, Global Patient Advocacy and External Partnerships, Pfizer UK

Sarah Holiday, Director, CX Research and Behavioral Science, Pfizer

2:35PM - 2:50PM

Enhancing Patient Engagement & Recruitment through Artificial Intelligence

Andrew Garvey, Global Patient Advocacy Lead, GSK

Eric Sandor, Executive Chairman, TrialX Inc.

2:50PM - 3:20PM

Boehringer-Ingelheim on Overcoming Barriers to Global Recruitment

Xoli Belgrave, Executive Director, Drug Development Services, Parexel

Bert Santy, Patient & Site Engagement Lead, Boehringer Ingelheim

Nicole Sheahan, President, Global Colon Cancer Association

Showing Events in 1 Track from 03:20pm to 04:10pm

HTA Assessment/Health Technology and Measuring Value of Patient Engagement Galleon Suites B & C

3:20PM - 3:45PM

Patient Involvement In Health Technology Assessment Processes – Focus On Training and Capacity Building

Amelia Hursey, MSc, Strategic Director, Parkinson’s Europe

Finn McCartney, MA, Project Manager, EUPATI

Léa-Isabelle Proulx, MA, PhD, Patient Voice Partner, Strategy, Portfolio & Operations, Roche

3:45PM - 4:10PM

Giving Study Participants a Voice: AstraZeneca’s Journey to Scaling the Study Participant Feedback Questionnaire

William Dott, Director, R&D Patient Science, AstraZeneca

Showing Events in 1 Track from 04:10pm to 04:15pm

Closing Remarks Galleon Suites B & C

4:10PM - 4:15PM

Closing Remarks

Showing Events in 1 Track from 08:30am to 09:00am

Morning Remarks
Galleon Suites B & C

8:30AM - 8:50AM

Morning Tea and Coffee

8:50AM - 9:00AM

Co-Chair Welcome

Co-Chairs:

Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi

Wafae Iraqi, PharmD, PhD, EMEA Patient Engagement Therapeutic Area Lead, Johnson & Johnson Innovative Medicine

Paul Isherwood, Senior Director, Patient Strategy and Insights, Parexel

Patient Keynote: If I Only Knew This?

Showing Events in 1 Track from 09:00am to 10:20am

Patient Keynote, Perspectives and Measuring Value
Galleon Suites B & C

9:00AM - 9:25AM

Creating the Right Environment for Patients to Provide Effective Insights into Clinical Trial Development

9:25AM - 9:55AM

Sarah Davies, Senior Director, Patient Strategy, Lumanity

Andy Collinson, Patient, Advocate

Daniel Newman, Patient, Advocate

Amanda Simonds, Global Patient Engagement & Advocacy Lead, Dermatology, UCB

9:55AM - 10:20AM

Measuring and Demonstrating the Value of Patient Engagement Across the Medicine Lifecycle

Christina Hughes, BS, MBA, Chief Operating Officer, Reverba Global

Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi

Anders Blaedel Lassen, Senior Director, Patient Insights, Lundbeck

Pascal Piedbois, MD, PhD, CMO, One2Treat

Showing Events in 1 Track from 10:20am to 10:55am

Morning Networking with Tea/Coffee and Biscuits

10:20AM - 10:55AM

Morning Networking with Tea/Coffee and Biscuits

Showing Events in 1 Track from 11:00am to 12:50pm

Partnerships, Advocacy and Turning Insights into Action
Galleon Suites B & C

11:00AM - 11:25AM

Johnson & Johnson Innovative Medicine on an End-to-End Matrix Approach to Patient Advocacy and Engagement

Wafae Iraqi, PharmD, PhD, EMEA Patient Engagement Therapeutic Area Lead, Johnson & Johnson Innovative Medicine

Beyza Klein, Director, Patient Advocacy R&D, Johnson & Johnson Innovative Medicine

11:25AM - 11:50AM

Patient Partnerships in Action: Integrating Patient Expertise into Product Innovation and Development

Lorna Allen, Involvement Manager, Cystic Fibrosis Trust

Rebecca Holmes, PhD, Scientific Director, LifeArc

Connie Takawira, Partnerships Manager, Medicines Discovery Catapult

11:50AM - 12:05PM

Patient Experience Journey Mapping – Methodology, Dissemination and Strategic Impact

Oleksandr Gorbenko, MD, PhD, BCMAS, Global Patient Affairs Director, Neurosciences, Ipsen

Ishmam Nawar, Communications Consultant, Oxford PharmaGenesis

12:05PM - 12:50PM

Interactive Session: Mapping the Patient Journey in Clinical Trials

Led By:

Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi

Kate Moss, Lead Partner, Pharmaceuticals & Life Sciences, Baringa

GSK on Advances in Decentralized Clinical Trials & Engaging with Patients Digitally

Showing Events in 1 Track from 12:50pm to 01:45pm

Lunch

12:50PM - 1:45PM

Lunch

Showing Events in 1 Track from 01:50pm to 03:20pm

DCT, Behavioural Science and Global Recruitment
Galleon Suites B & C

1:50PM - 2:10PM

Laura Renton, Digital Enablement Lead, GSK

2:10PM - 2:35PM

Who are Trusted Messengers for Patient Engagement in Real World Data Studies? A Behavioural Science Approach

Speaker:

Sally Dews, Director, Global Patient Advocacy and External Partnerships, Pfizer UK

Sarah Holiday, Director, CX Research and Behavioral Science, Pfizer

2:35PM - 2:50PM

Enhancing Patient Engagement & Recruitment through Artificial Intelligence

Andrew Garvey, Global Patient Advocacy Lead, GSK

Eric Sandor, Executive Chairman, TrialX Inc.

2:50PM - 3:20PM

Boehringer-Ingelheim on Overcoming Barriers to Global Recruitment

Xoli Belgrave, Executive Director, Drug Development Services, Parexel

Bert Santy, Patient & Site Engagement Lead, Boehringer Ingelheim

Nicole Sheahan, President, Global Colon Cancer Association

Showing Events in 1 Track from 03:20pm to 04:10pm

HTA Assessment/Health Technology and Measuring Value of Patient Engagement
Galleon Suites B & C

3:20PM - 3:45PM

Patient Involvement In Health Technology Assessment Processes – Focus On Training and Capacity Building

Amelia Hursey, MSc, Strategic Director, Parkinson’s Europe

Finn McCartney, MA, Project Manager, EUPATI

Léa-Isabelle Proulx, MA, PhD, Patient Voice Partner, Strategy, Portfolio & Operations, Roche

3:45PM - 4:10PM

Giving Study Participants a Voice: AstraZeneca’s Journey to Scaling the Study Participant Feedback Questionnaire